Table 4.
Scores (95% confidence intervals) for continuous measures by cohort and stage
|
Gulf
|
Bosnia
|
Era
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Stage 1 | Stage 2 | Difference | Stage 1 | Stage 2 | Difference | Stage 1 | Stage 2 | Difference | |
| SF-36* physical function | 90.3 (88.3 to 91.3) | 88.7 (87.6 to 89.9) | −1.6 (−2.5 to −0.7) | 95.4 (94.4 to 96.4) | 92.9 (91.6 to 94.1) | −2.6 (−3.8 to −1.3) | 92.1 (90.6 to 93.6) | 90.8 (89.2 to 92.3) | −1.3 (−2.7 to 0.1) |
| SF-36* health perception | 65.8 (64.1 to 67.5) | 65.9 (64.2 to 67.6) | 0.1 (−1.2 to 1.4) | 76.2 (74.4 to 77.9) | 72.9 (71.0 to 74.8) | −3.3 (−5.1 to −1.6) | 76.8 (75.0 to 78.6) | 74.4 (72.4 to 76.4) | −2.4 (−4.2 to −0.6) |
| General health questionnaire | 14.5 (14.1 to 14.9) | 14.2 (13.8 to 14.5) | −0.3 (0.1, −0.6) | 13.1 (12.7 to 13.6) | 13.2 (12.7 to 13.7) | 0.1 (−0.4 to 0.6) | 12.4 (12.0 to 12.8) | 12.9 (12.5 to 13.3) | 0.5 (0.05 to 1.0) |
| Fatigue | 17.8 (17.4 to 18.1) | 16.9 (16.5 to 17.2) | −0.9 (−1.2 to −0.6) | 15.6 (15.2 to 16.0) | 15.3 (14.9 to 15.7) | −0.3 (−0.7 to 0.2) | 14.7 (14.3 to 15.0) | 14.9 (14.5 to 15.3) | 0.2 (−0.2 to 0.6) |
| Total symptoms | 11.0 (10.4 to 11.6) | 10.7 (10.1 to 11.3) | −0.3 (−0.8 to 0.1) | 6.2 (5.6 to 6.8) | 7.9 (7.3 to 8.5) | 1.7 (1.2 to 2.3) | 5.3 (4.8 to 5.8) | 6.4 (5.8 to 7.0) | 1.1 (0.6 to 1.6) |
All scores are weighted for sampling.
For SF-36 scores, negative differences in mean indicate a worsening in health. For other scales, negative scores indicate an improvement in health.
*
SF-36 scales range from 0-100, with higher scores indicating better health.